STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 100 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,876,000 | +54.2% | 1,023,159 | +51.0% | 1.62% | +33.4% |
| Q3 2019 | $7,055,000 | -30.9% | 677,759 | +1.7% | 1.22% | -0.2% |
| Q2 2019 | $10,206,000 | +33.3% | 666,158 | +11.8% | 1.22% | +32.5% |
| Q1 2019 | $7,659,000 | +1975.6% | 596,058 | +1434.7% | 0.92% | +1742.0% |
| Q4 2018 | $369,000 | +19.8% | 38,838 | +109.5% | 0.05% | +51.5% |
| Q3 2018 | $308,000 | – | 18,538 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 1,471,518 | $23,618,000 | 8.40% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 492,930 | $7,862,000 | 3.02% |
| Consonance Capital Management LP | 2,747,198 | $44,093,000 | 2.84% |
| NEXTHERA CAPITAL LP | 559,517 | $8,980,000 | 1.39% |
| Eventide Asset Management | 1,086,400 | $17,437,000 | 0.72% |
| Virtus ETF Advisers LLC | 45,850 | $736,000 | 0.65% |
| KNOTT DAVID M | 90,000 | $1,445,000 | 0.54% |
| Polar Capital LLP | 1,912,605 | $30,697,000 | 0.18% |
| Artal Group S.A. | 400,000 | $6,420,000 | 0.14% |
| J. Goldman & Co LP | 100,000 | $1,605,000 | 0.08% |